CONTOUR®PLUS Blood Glucose Test Strips

Compatible with CONTOUR®PLUS and CONTOUR®PLUS BLUE blood glucose meters.

Product Features

  • Only a tiny sample size of 0.6µl is required
  • Second-Chance® sampling allows you 30 seconds to apply more blood to the same strip if the first sample was insufficient
  • All CONTOUR®PLUS blood glucose monitoring systems have been demonstrated to meet all requirements of ISO 15197:20131

CONTOUR®PLUS test strip benefits

Test in three simple steps

Small amount of blood required

Your test strip is designed to easily "sip" the blood into a sample tip. Only a small 0.6µl sample size is needed.

Second-Chance Sampling

Second Chance® Sampling

Second-Chance® sampling allows you 30 seconds to apply more blood to the same strip if the first sample was insufficient with CONTOUR®PLUS and CONTOUR®PLUS BLUE meters.

Unaffected by common interfering substances

Unaffected by common interfering substances

CONTOUR®PLUS test strips deliver results that are unaffected by many common interfering substances occurring naturally in the blood (i.e. cholesterol or haemoglobin) and occurring from therapeutic treatments such as paracetamol or ibuprofen and others.2,3

Work with

CONTOUR®PLUS BLUE blood glucose meter

Learn more >

CONTOUR®PLUS blood glucose meter

Learn more >
Learn more >

FAQs

Have a look at our FAQs here.

Contact us

Would you like to know more about one of our products? Visit our contact us page.

Package insert

pdf-svgrepo-com.svgCONTOUR®PLUS Test Strips

1. International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2013.
2. McEnroe RJ, et al. Interference Testing in Clinical Chemistry; Approved Guideline—Second Edition. EP7-A2, vol 25, no 27. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
3. Brown D et al. Interference Evaluation for the CONTOUR®PLUS Test Strip. Poster presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), 2-5 June, 2021.